東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

The Impact of Drug Profit Margins on...

Lo, Sheng-Hao.

Linked to FindBook

Google Book

Amazon

博客來

The Impact of Drug Profit Margins on Medical Providers, Patients, and the Government.

Record Type:	Electronic resources : Monograph/item
Title/Author:	The Impact of Drug Profit Margins on Medical Providers, Patients, and the Government./
Author:	Lo, Sheng-Hao.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
Description:	65 p.
Notes:	Source: Dissertations Abstracts International, Volume: 83-02, Section: B.
Contained By:	Dissertations Abstracts International83-02B.
Subject:	Health care management. -
Online resource:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28497787
ISBN:	9798516957352

The Impact of Drug Profit Margins on Medical Providers, Patients, and the Government.
Lo, Sheng-Hao.

The Impact of Drug Profit Margins on Medical Providers, Patients, and the Government. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 65 p.

Source: Dissertations Abstracts International, Volume: 83-02, Section: B.

Thesis (Ph.D.)--The University of Chicago, 2021.

This item must not be sold to any third party vendors.

This paper examines hospital--patient agency issue in the context of Taiwan's prescription drug market, in which hospitals receive profit by both prescribing and dispensing drugs. Using Taiwanese claim-based, outpatient-visit data and proprietary market survey data from 2013 to 2018, I identify an empirically important dimension of variation in drug profit margins in how much hospitals profit by prescribing the same drug, accounting for more than 50% of total variation. In particular, I find that private hospitals and those with large order volumes enjoy higher profit margins for a given drug, and the relationship is more pronounced among drugs with weaker market positions. I use the average reimbursement price of each drug as an instrument, and use 2SLS to demonstrate that a 10 percentage point increase in the drug profit margin is associated with a 1 percent increase in drug demand, suggesting a hospital's agency problem. I then show a significant increase in drug expenditures paid by the government and number of drugs dispensed to patients, but with no significant change to copayments paid by patients. These findings provide empirical evidence of substantial impact of prescribing high-margin drugs on Taiwan's national health insurance under current regulation.

ISBN: 9798516957352Subjects--Topical Terms:

2122906
Health care management.
Subjects--Index Terms:

Moral hazard

The Impact of Drug Profit Margins on Medical Providers, Patients, and the Government.
LDR:02506nmm a2200373 4500 001 2284928
005 20211124093256.5
008 220723s2021 ||||||||||||||||| ||eng d
020 $a 9798516957352
035 $a (MiAaPQ)AAI28497787
035 $a AAI28497787
040 $a MiAaPQ $c MiAaPQ
100 1 $a Lo, Sheng-Hao. $3 3564146
245 1 4 $a The Impact of Drug Profit Margins on Medical Providers, Patients, and the Government.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 65 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-02, Section: B.
500 $a Advisor: Gottlieb, Joshua D.;Grogger, Jeffery.
502 $a Thesis (Ph.D.)--The University of Chicago, 2021.
506 $a This item must not be sold to any third party vendors.
520 $a This paper examines hospital--patient agency issue in the context of Taiwan's prescription drug market, in which hospitals receive profit by both prescribing and dispensing drugs. Using Taiwanese claim-based, outpatient-visit data and proprietary market survey data from 2013 to 2018, I identify an empirically important dimension of variation in drug profit margins in how much hospitals profit by prescribing the same drug, accounting for more than 50% of total variation. In particular, I find that private hospitals and those with large order volumes enjoy higher profit margins for a given drug, and the relationship is more pronounced among drugs with weaker market positions. I use the average reimbursement price of each drug as an instrument, and use 2SLS to demonstrate that a 10 percentage point increase in the drug profit margin is associated with a 1 percent increase in drug demand, suggesting a hospital's agency problem. I then show a significant increase in drug expenditures paid by the government and number of drugs dispensed to patients, but with no significant change to copayments paid by patients. These findings provide empirical evidence of substantial impact of prescribing high-margin drugs on Taiwan's national health insurance under current regulation.
590 $a School code: 0330.
650 4 $a Health care management. $3 2122906
650 4 $a Asian studies. $3 1571829
650 4 $a Prescription drugs. $3 3562003
650 4 $a Pharmaceuticals. $3 3562593
650 4 $a Chronic illnesses. $3 3550688
653 $a Moral hazard
653 $a National Health Insurance
653 $a Prescription drug market
653 $a Profit margin
653 $a Taiwan's prescription drug market
690 $a 0501
690 $a 0769
690 $a 0342
710 2 $a The University of Chicago. $b Economics. $3 1672980
773 0 $t Dissertations Abstracts International $g 83-02B.
790 $a 0330
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28497787